Clinical applications of liquid biopsy in non-small-cell lung cancer
Join Dr Joop de Langen from the Netherlands Cancer Institute, Amsterdam, The Netherlands, as he reviews the current clinical applications of liquid biopsy in non-small cell lung cancer. Dr de Langen provides practical case studies alongside the B-FAST data evaluating the use of ctDNA to help detect primary drivers and identification of resistance mechanisms in lung cancer.
Subscribe to our YouTube channel now: https://www.youtube.com/user/r....oche?sub_confirmatio
Get in touch with us:
https://www.roche.com/
https://twitter.com/roche
https://www.linkedin.com/company/roche
https://www.facebook.com/roche
https://www.instagram.com/roche
Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the worldโs largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
For more information and insights visit: https://www.roche.com/
-
Category
No comments found